Emily Elizabeth Bonner DeVille
Keine laufenden Positionen mehr
Profil
Emily Elizabeth Bonner DeVille worked as Vice President of Communications & Training at Pernix Therapeutics, Inc. and Vice President of Sales & Compliance at Pernix Therapeutics Holdings, Inc. She also worked as Manager of Business Development at Praeses Corp.
Bonner DeVille earned an undergraduate degree from Centenary College of Louisiana.
Ehemalige bekannte Positionen von Emily Elizabeth Bonner DeVille
| Unternehmen | Position | Ende |
|---|---|---|
| Pernix Therapeutics, Inc. | Public Communications Contact | - |
| Praeses Corp. | Corporate Officer/Principal | - |
| PERNIX THERAPEUTICS HOLDINGS INC | Compliance Officer | - |
Ausbildung von Emily Elizabeth Bonner DeVille
| Centenary College of Louisiana | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
| Pernix Therapeutics, Inc. | Health Technology |
| Praeses Corp. |
